Introduction
Fig. 1 A-F Human atrial myocardium. Representative light microscopic images of semi-thin sections of Eponembedded material stained with toluidine blue. Note the atrial ICLC with very long, thin processes, delineated by red dotted lines, and disposed around the working cardiomyocytes (oblique and cross sections A-D and longitudinally-cut in E, F). The punctate brown staining corresponds to lipofuscin pigment granules. Scale bars = 10μm.
A B [12] ; female [13] [14] [15] or male [16, 17] reproductive tract; upper [18] or lower [19] [20] [21] urinary tract; mammary gland [22] , etc. Moreover, besides the well-known gastrointestinal stromal tumors (socalled GISTs), which start from ICC, extra-GISTs are now considered a new pathological entity, originating probably from ICLC [23] . Our working hypothesis was that ICLC could exist in the interstitium of atrial myocardium. Indeed, we previously presented electron microscope images, strongly suggesting that ICLC could be identified in human atrial myocardium [24] . This might be surprising for many electron microscopists, because the trivial belief is not very far from the following: '...despite electron microscopy having been used for a considerable time relatively few cases appeared to benefit directly from this investigation' [25] .
Myocardial interstitium was mostly overlooked, since, on the one hand, people were focused on muscle cells and their atrial granules, or, on the other hand, the ultrastructure of the interstitial space seems rather monotonous. In this context, it was hard to believe for morphologists that a novel cell type could still exist in the myocardium.
In the heart, fibroblasts form one of the largest cell populations, in terms of cell numbers [26, 27] , and most recent studies point out their structural and functional heterogeneity [28] . Therefore, ICLC, that share common features with some 'classical' fibroblasts, might be in fact a subpopulation of the atrial interstitial cells, taken in toto as 'fibroblasts'.
We present here correlated morphological, ultrastructural and immunocytochemical data that confirm the presence of ICLC in human and rat atrial myocardium.
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Material and methods
Human tissue samples
The study was performed on archived atrial Epon-embedded tissue specimens, obtained with written consent from patients undergoing cardiac surgery. 
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of atrial ICLC ultrastructural characteristics, (e.g. relative volumes occupied by different cells, or organelles etc.) was performed using the classical test-system described by Weibel [29] .
Animal tissue samples
Male Wistar rats weighing 200-250 g, fed ad libitum on stock diet, according to the local ethical guidelines were euthanised with an overdose of the anesthetic. Right atrium tissue samples were obtained and processed, as described above, for morphological studies. 
Non-conventional light microscopy (NCLM)
Control semi-thin sections (less than 1 µm) were stained with 0.25% toluidine blue and examined by light microscopy (Nikon Eclipse E600). Representative photomicrographs were taken using Nikon Plan 40x and Nikon Plan Fluor 100x/1.30 oil.
Morphometric analysis
NCLM. Twenty-four randomly taken images were analysed to determine the relative volume occupied by ICLC. Volumes were expressed as percentage, using superimposed Weibel grids [29] . ICLC number and morphology was evaluated on 32 photomicrographs (~700 cells were counted). Data were processed and statistically analysed using Microsoft Excel software.
TEM. Detailed quantitative analysis of size and length of ICLC prolongations, as well as distances to targets (or stromal synapse nanoscopy) was performed on TEM images with known magnifications, using NIH ImageJ software, after proper calibration. Statistical analysis of these parameters was also performed using ImageJ.
Immunohistochemistry (IHC)
IHC was performed on formalin-fixed, paraffin-embedded tissue sections by the avidin-biotin peroxidase complex method [30, 31] . The primary antibodies used were as follows: CD117/c-kit, polyclonal, 1:100 (DAKO, Glostrup, Denmark), CD34, monoclonal, 1: 100, clone QBEND10 
Atrial interstitial-cell isolation protocol
Male Wistar rat (4 weeks) was killed by cervical dislocation. The heart was removed and immediately placed in 2 , and maintained at 37°C, in a humidified atmosphere (5% CO 2 in air) until becoming semi-confluent (usually 4 days after plating).
The protocols used for MitoTracker Green FM, methylene blue and Giemsa stainings were previously described [13] . Silver impregnation on cell cultures was done as follows: cells were fixed with paraformaldehyde 2% for 10 min, at 4 o C, washed 3 times in ethanol 80% and then incubated with silver nitrate 20%, for 30 min. Coverslips were then washed 3 times with water and covered with paraformaldehyde 20% for 3 min and then with amoniacal silver nitrate solution for 30 sec. Slides were then washed in distilled water, fixed in thiosulphate 5% and mounted in Entellan (Merck KGaA, Darmstadt, Germany).
Results
The toluidine blue staining of semi-thin sections from human atrium shows that ICLC are located among the working atrial myocytes. A strange morphological event is illustrated in Fig.  2 . An extracellular lipid droplet (probably lipofuscin pigment) is surrounded by the ending of a long ICLC process. The presence of extracellular lipid material in myocardium has been previously documented [32] . Fig. 3 shows that about half of ICLC population has two prolongations per cell body, whilst only about 15% of ICLC have three cell processes.
In terms of relative volumes, ICLC seem to represent about 1.2+0.3% of the atrial myocardial volume vs. 44.9+2.9% working myocytes, 1.8+0.6% endothelial cells, 3.5+1.1 other interstitial cells, 48.6+2.5% extracellular matrix (Fig. 4) .
Electron microscopy. TEM images obtained from both human and rat atrial ultrathin-sections have been digitally colored, in order to make ICLC (turquoise) more evident. Cells that were identified as ICLC fulfill ultrastructural criteria for positive diagnosis, proposed as an elegant 'gold standard' [33] and subsequently refined as 'platinum standard' [13] (Fig. 6 ) and unevenly distributed atrial granules (Figs. 5A-C, 6, 7B,D, 8D, 9A,B, 10A,B) .
IHC. The polyclonal antibodies used against CD117/c-kit resulted in weakly and inconstantly positive immunostaining of ICLC (Fig. 12A) . Mast cells were also positive for CD117. The differential diagnosis was based on cell shape and prolongations (for ICLC) and the granular appearance (for mast cells). ICLC expressed CD34 antigen in human atrial tissue specimens (Fig. 12B) , and a network-like morphology was sometimes observed. However, CD34 alone may lead to an over-estimation of ICLC number, since CD34 might be expressed also by fibroblasts and endothelial cells. Vimentin was found strongly positive (Fig. 12C,D) along the ICLC cytoplasmic prolongations. Vimentin positive (c-kit negative) cells were found by Duquette et al. in pregnant human uterus [14] and considered such cells as being interstitial Cajallike cells. We previously reported that c-kit positive cells, with ICLC morphology under the electron microscope, were present in human pregnant and non-pregnant myometrium [15] .
Since the receptor for the epidermal growth factor (EGF-R) is considered the prototype for receptors with tyrosine kinase activity (related to c-kit receptor) and EGF-R is present on many cell types, we tested EGF-R expression by ICLC. (Un)expectedly, some atrial ICLC indeed appeared EGF-R positive (Fig. 12E-G) .
ICLC were positive for α-smooth muscle actin and tau protein, and negative for nestin and S-100.
IHC for desmin showed the lack of expression at the level of ICLC, concomitantly with immunopositive reactions in working myocytes.
CD13 (Aminopeptidase N) is a transmembrane protease present in a wide variety of human cell types (endothelial, epithelial, fibroblast, leukocyte) and the negative immunoreaction that we found supported the differential diagnosis vs. classical fibroblasts [34] .
In vitro, mitochondria retained the vital stain MitoTracker Green FM, corresponding with dilations of cytoplasmic processes, observed by Hoffman modulation contrast microscopy.
Typical ICLC (Fig. 13E,F) were easily recognized in cell culture using a vital dye: methylene blue. The selectively stained cells were designated as ICLC.
Similar result were obtained using Giemsa stain, since it is a mixture containing methylene-blue eosinate and methylene-blue chloride, dissolved in methyl alcohol, with glycerol as a stabiliser. Silver impregnation demonstrated specific staining of ICLC in situ [13] and we applied the same method to cells in culture. Indeed, ICLC with particular morphology (two or more very long, moniliform processes) stained selectively (Fig. 13H,I ).
Discussion
This study provides further proof for the ICLC presence in human and rat atrial myocardium. To our knowledge, the existence of ICLC in the heart was overlooked until now. Table I presents [based on refs. [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] an incomplete survey of literature incidentally documenting (but ignoring) the occurence of ICLC or cell processes/fragments, in atrial myocardium. According to actual criteria for ultrastructural diagnosis [9, 13, 33] , such cells can now be classified as putative ICLC.
Based on our algorythm for ICLC identification, the cells described in this study meet these criteria. The main issue might be that ICLC could be fibroblasts or myofibroblasts. Since 'fibroblasts are principally motile cells that contain actin (mainly α-smooth muscle actin) and myosin' [28] , the absence of thick filaments does represent a pro-ICLC argument. Also, in situ ICLC have caveolae (while fibroblasts have caveolae only in cell culture), the level of development of rough endoplasmic reticulum (very abundant in fibroblasts), the presence of basal lamina, very 'special' cell processes etc., all these are additional arguments.
Noteworthy, myofibroblasts are 'not a typical component of normal untraumatised tissues' [48] , although the structural remodeling of the myocardium (associated with mechanical overload or cardiac infarction) may be accompanied by the appearance of myofibroblasts [49] . Anyway, the ultrastructural obligatory criteria for myofibroblasts [50, 51] are not accomplished in the case of 'our' ICLC:
(i) stress fibers; (ii) cell-to-stroma attachment sites (fibronexuses); (iii) intercellular intermediate (adherens) and gap junctions. The close plasmalemmal appositions that bring ICLC and macrophage together in a multicontact type stromal synapse, presented in Fig. 11 , offers a signaling structural platform, being well within the molecular range [52] . We have previously identified stromal synapses in various organs (between ICLC and immunoreactive cells), supporting the hypothesis that stromal immunoreactive cells are included among the ICLC targets in interstitial intercellular communication.
Identification of ICLC confirms the belief that information made available by TEM is usually not available by other approaches [53] . IHC may add value to TEM analysis.
Further investigation must be undertaken before presumptions about physiological significance (or lack of significance) of tau protein positivity in ICLC can be made.
Conventional and non-conventional light microscopy including immunocytochemistry are not enough for the positive diagnosis of ICLC, but are useful for quantitative data analysis, evaluation of relationships with target cells (working myocytes, nerve fibers, capillaries). Analysis of ultrastructural features by TEM still remains decisive for the positive diagnosis of ICLC.
Because of their position in interstitium, ICLC might be presumed as potential:
1) players in pacemaking, including arrhythmogenesis; 2) intermediates between intrinsic nerve fibres and myocytes (intercellular signaling); 3) a paracrine and/or juxtacrine source of signal molecules 4) mechanical transducers; 5) local 'triggers' for atrial granules content release; 6) tissue 'organizers' during development; uncommitted progenitor cells; 7) the 'neglected' component of tissue architecture during remodeling.
Instead of conclusion
Why ICLCs should not be the hearts of the heart?
